Plasma tissue factor pathway inhibitor levels in patients with acute pancreatitis
โ Scribed by Takeo Yasuda; Takashi Ueda; Keiko Kamei; Wataru Shinzaki; Hidehiro Sawa; Makoto Shinzeki; Yonson Ku; Yoshifumi Takeyama
- Publisher
- Springer Japan
- Year
- 2009
- Tongue
- English
- Weight
- 629 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
We measured the plasma levels of tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in patients with disseminated intravascular coagulation (DIC) to examine the relationship between TFPI and vascular endothelial cell injury. Plasma TF (273 ยฑ 90 pg/ml) and TFPI (252 ยฑ 125 ng/ml) levels wer
We measured the plasma levels of tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in patients with disseminated intravascular coagulation (DIC) to examine the relationship between TFPl and vascular endothelial cell injury. Plasma TF (273 2 90 pg/ml) and TFPl (252 2 125 nglml) levels wer
We examined hemostatic abnormalities in 23 patients with acute myocardial infarction (AMI), 10 with pulmonary embolism (PE), and 10 with deep vein thrombosis (DVT). At the onset of AMI, plasma levels of tissue-type plasminogen activator (t-PA), PA inhibitor-I (PAI-I), fibrin-D-dimer, thrombin-antith
To evaluate that the relationship between the truncated form of tissue factor pathway inhibitor (TFPI) and the stage of disseminated intravascular coagulation (DIC), we measured the plasma levels of tissue factor (TF) antigen and the intact and truncated forms of TFPI antigens in 41 patients with DI
Plasma levels of tissue factor pathway inhibitor (TFPI)-activated factor Xa (FXa) complex were measured in patients with disseminated intravascular coagulation (DIC), pre-DIC, and DIC. Plasma levels of plasmin-plasmin inhibitor complex (PPIC), D-dimer, and soluble fibrin monomer (SFM) were significa